Sat. Apr 17th, 2021

MANILA, Philippines – On the 78th occasion of the Araw ng Kagitingan (Day of Valor) Thursday, the Commission on Human Rights (CHR) honored frontliners amid the COVID-19 pandemic.

The commission likened their courage to heroic Filipino soldiers who wages their lives in the Second World War II.

“Bigyang-pugay natin muli ang mga beteranong lumaban para sa kalayaan at kaligtasan ng bayan noong panahon ng World War II. Ang kanilang katapangan, kahandaang mag-sakripisyo, at mag-alay ng buhay ay mga katangian na nananalaytay sa mga kasalukuyang bayani ng ating bayan,” CHR Spokesperson Ms. Jacqueline de Guia said.

 “Sa gitna ng krisis sa kalusugan, maihahalintulad ang giting at tapang ng mga frontliners sa mga bayani noong panahon ng digmaan. Sa kabila ng panganib na dulot ng coronavirus disease-19 (COVID-19), sila ay matapang na nag-se-serbisyo at nag-sa-sakripisyo araw-araw.”

De Guia also said the public can help and pay tribute to health workers by simply following safety protocols against COVID-19 like social distancing, proper hygiene practices, by helping the poor, through volunteerism among others.

 “Tayong lahat ay maaaring maging bayani at makipagbayanihan sa ating simpleng paraan para maitaguyod ang karapatan at dignidad ng ating mga kapwa Pilipino,” de Guia stressed.

And in unity, she said, every Filipino could emerge victorious out of the sweeping health crisis.

 “Katulad ng mga nagdaang pakikibaka ng ating bayan, kapag pinagsama-sama ang mga kabutihan at sakripisyo ng bawat isa, mapagtatagumpayan natin ang kasalukuyang hamon sa kalusugan,” she added.

Like the CHR, several lawmakers have likewise commended the country’s health care front-liners by risking their own lives.

They also likened them to WWII soldiers in the fight against the killer virus. (IAMIGO/SovereignPH.com)

Read more: https://newsinfo.inquirer.net/1256652/chr-honors-covid-19-frontliners-on-day-of-valor-likens-them-to-wwii-soldiers#ixzz6JAsZmAl5

Follow us: @inquirerdotnet on Twitter | inquirerdotnet on Facebook

Leave a Reply